N-(3-Methoxybenzyl)palmitamideCAS# 847361-96-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 847361-96-0 | SDF | Download SDF |
PubChem ID | 71765531 | Appearance | Powder |
Formula | C24H41NO2 | M.Wt | 375.6 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | N-[(3-methoxyphenyl)methyl]hexadecanamide | ||
SMILES | CCCCCCCCCCCCCCCC(=O)NCC1=CC(=CC=C1)OC | ||
Standard InChIKey | FIQGQTITXPTKIY-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C24H41NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-19-24(26)25-21-22-17-16-18-23(20-22)27-2/h16-18,20H,3-15,19,21H2,1-2H3,(H,25,26) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. N-(3-Methoxybenzyl)palmitamide can counteract the toxicity produced by Aβ (25-35). 2. N-(3-methoxybenzyl)palmitamide is a promising inhibitor of fatty acid amide hydrolase (FAAH) and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders. |
Targets | Beta Amyloid | Caspase |
N-(3-Methoxybenzyl)palmitamide Dilution Calculator
N-(3-Methoxybenzyl)palmitamide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6624 mL | 13.312 mL | 26.6241 mL | 53.2481 mL | 66.5602 mL |
5 mM | 0.5325 mL | 2.6624 mL | 5.3248 mL | 10.6496 mL | 13.312 mL |
10 mM | 0.2662 mL | 1.3312 mL | 2.6624 mL | 5.3248 mL | 6.656 mL |
50 mM | 0.0532 mL | 0.2662 mL | 0.5325 mL | 1.065 mL | 1.3312 mL |
100 mM | 0.0266 mL | 0.1331 mL | 0.2662 mL | 0.5325 mL | 0.6656 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Fmoc-L-Beta-Homoproline
Catalog No.:BCN8087
CAS No.:193693-60-6
- LY2784544
Catalog No.:BCC2200
CAS No.:1229236-86-5
- C 21
Catalog No.:BCC8013
CAS No.:1229236-78-5
- GS-9973
Catalog No.:BCC5278
CAS No.:1229208-44-9
- Edoxaban tosylate monohydrate
Catalog No.:BCC1545
CAS No.:1229194-11-9
- 3-O-Acetylandrostenone hydrazone
Catalog No.:BCC8637
CAS No.:122914-94-7
- GSK 9027
Catalog No.:BCC6115
CAS No.:1229096-88-1
- Tatarinoid A
Catalog No.:BCN6119
CAS No.:1229005-35-9
- 12-Demethylneocaesalpin F
Catalog No.:BCN6410
CAS No.:1228964-10-0
- MLN0905
Catalog No.:BCC3961
CAS No.:1228960-69-7
- Ziprasidone HCl
Catalog No.:BCC2511
CAS No.:122883-93-6
- Mps1-IN-2
Catalog No.:BCC4153
CAS No.:1228817-38-6
- XE 991 dihydrochloride
Catalog No.:BCC7232
CAS No.:122955-13-9
- URMC-099
Catalog No.:BCC5563
CAS No.:1229582-33-5
- 6'-O-Galloyl paeoniflorin
Catalog No.:BCN2941
CAS No.:122965-41-7
- HA 130
Catalog No.:BCC7884
CAS No.:1229652-21-4
- RG7388
Catalog No.:BCC1895
CAS No.:1229705-06-9
- Fmoc-Hyp(tBu)-OH
Catalog No.:BCC3256
CAS No.:122996-47-8
- 4-Hydroxybenzaldehyde
Catalog No.:BCN5816
CAS No.:123-08-0
- Anisic aldehyde
Catalog No.:BCN2618
CAS No.:123-11-5
- D-erythro-Sphingosine (synthetic)
Catalog No.:BCC6729
CAS No.:123-78-4
- Azelaic Acid
Catalog No.:BCC8300
CAS No.:123-99-9
- Azasetron HCl
Catalog No.:BCC5035
CAS No.:123040-16-4
- Bulleyanin
Catalog No.:BCN6120
CAS No.:123043-54-9
New flavonoids with 2BS cell proliferation promoting effect from the seeds of Trigonella foenum-graecum L.[Pubmed: 20349151]
J Nat Med. 2010 Jul;64(3):358-61.
Ten flavonoids were isolated from the ethyl acetate-soluble fraction of the ethanolic extract of the seeds of Trigonella foenum-graecum and their structures were elucidated on the basis of spectroscopic methods to be 5,7,3'-trihydroxy-5'-methoxylisoflavone (1), biochanin A (2), formononetin (3), irilone (4), tricin (5), daidzein (6), calycosin (7), orientin-2''-O-p-trans-coumarate (8), Vitexin-2''-O-p-trans-coumarate (9), and tricin-7-O-beta-D: -glucopyranoside (10). Compounds 1 and 8 are new flavonoids, and 8 and 9 strongly promoted 2BS cell proliferation induced by H(2)O(2).